Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.

Nagel, G A; Wander, H E; Blossey, H C

Nagel, G A; Wander, H E; Blossey, H C.

Cancer Res ; 42(8 Suppl): 3442s-3444s, 1982 Aug.

Article in En | MEDLINE | ID: mdl-6123383

Subject(s)

Aminoglutethimide/administration & dosage; Breast Neoplasms/drug therapy; Medroxyprogesterone/administration & dosage; Adrenocorticotropic Hormone/blood; Aminoglutethimide/adverse effects; Body Weight/drug effects; Depression/chemically induced; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Fatigue/chemically induced; Female; Humans; Hydrocortisone/blood; Medroxyprogesterone/adverse effects; Middle Aged; gamma-Glutamyltransferase/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Aminoglutethimide / Medroxyprogesterone Limits: Female / Humans / Middle aged Language: En Journal: Cancer Res Year: 1982 Type: Article

Search on Google

XML

PubMed Links